ADPT Adaptive Biotechnologies Corporation

NASDAQ
$24.74

Adaptive Biotechnologies Corporation (ADPT) is expected to report earnings on October 28, 2026, after the market close. The consensus earnings estimate is a loss of $0.10 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +11.4% since its last earnings release on July 29, 2026.

Adaptive Biotechnologies Reported In-line with Expectations, Raises Guidance
Wednesday, July 29, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 28
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs ($0.10)
Rev est $70.27M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $24.33

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Adaptive Biotechnologies Corporation

Adeptus Health Inc owns and operates First Choice Emergency Rooms, the network of independent freestanding emergency rooms in the United States.

Sector

Healthcare

Industry

Medical Labs & Research

Held By 1 ETFs, by dollar flow